Increasing risk of cataract in HCV patients receiving anti-HCV therapy: A nationwide cohort study.
Shih-Yi LinCheng-Li LinShu-Woei JuI-Kuan WangCheng-Chieh LinChih-Hsueh LinWu-Huei HsuJi-An LiangPublished in: PloS one (2017)
HCV infection, even without the complication of cirrhosis, is associated with an increased risk of cataract, and this risk is higher in HCV-infected patients undergoing interferon-ribavirin therapy.